Meet our Deal Professionals


Chris Ehrlich
Chris Ehrlich

Chief Executive Officer, Locust Walk Acquisition Corp.
Contact Us

Chris Ehrlich is Chief Executive Officer of Locust Walk Acquisition Corp. He brings significant biotechnology industry and venture capital experience. Since joining Locust Walk in 2013, Chris has been involved with leading multiple transactions for emerging biopharmaceutical companies including orchestrating the sale of Xyphos Biosciences to Astellas for up to $660 million, as well as assisting TesoRx in their licensing deals with Aspen Pharma and Aska, and Thar Pharmaceuticals with their acquisition by Grunenthal and Cymabay in their licensing deal with Kowa Pharmaceuticals. He has also served as an expert witness in several recent biotechnology cases.

Prior to Locust Walk, he was a Managing Director at InterWest Partners (“IW”). At IW he served on the boards of KAI Pharmaceuticals as the Lead Director (acquired by Amgen), Biomimetic Therapeutics, Inc. (NASD: BMTI, acquired by Wright Medical Technologies, then acquired by Stryker), Invuity (NASD: IVTY, acquired by Stryker) and Xenon Pharmaceuticals (NASD: XENE).  At all four companies, he sat on the transaction committees where he oversaw numerous business development and financing deals.

Prior to joining InterWest, Chris was the Director of Licensing and Business Development at Purdue Pharma, a private pharmaceutical firm based in Stamford, CT. In this position, Chris was responsible for developing a biologic oncology franchise, including in-licensing key intellectual properties, establishing and managing collaborations with biotechnology companies and leading the commercial operations of Purdue BioPharma, a biotechnology company located in Princeton, NJ.

Prior to joining Purdue, Chris worked in business development at Genentech, in venture capital at the U.S. Russia Investment Fund, and in biotechnology strategy development at LEK Consulting.

Chris received his undergraduate degree, cum laude, from Dartmouth College and an MBA from the Kellogg School of Management at Northwestern University. Chris is also a proud graduate of The Rivers School in Weston, MA where, in 2018, he received the Alumni Excellence Award.

Chris currently serves on the Board of Directors of Prostate Management Diagnostics, Inc., on the Advisory Board of the Peter Michael Foundation, where he is a Senior Advisor, and on the Healthcare at Kellogg Advisory Board at Northwestern University. Chris is also a member of the Young Presidents Organization.

Chris lives in San Francisco with his wife Sara, and two kids, Charlotte and Harrison. He is a registered rep with FINRA, holding his Series 79, 63 and 24 licenses.